What a VC Is Really Saying When It Says ‘Not a Fit’

Founders commonly treat vague investor feedback as a verdict on their product, team or pitch. The better reading is often institutional: classify the pass by what the investor did, not merely what they said, before changing the business.

On 13 August 2026, CRV, the US early-stage venture-capital firm, published a guide to something founders usually experience alone: the pass that arrives after a meeting that seemed to go well.

The language is familiar. *Too early for us.* *Not quite a fit right now.* *We will be watching with interest.* Sometimes there is no language at all. A founder sends a follow-up, then another, and watches a promising conversation evaporate.

It is tempting to convert that quiet into a story about the company. The product was not convincing. The market was too small. The deck was weak. Perhaps the investor simply did not have the decency to say no.

CRV’s point was more unsettling, and more useful. There are two kinds of no: one a founder can fix, and one that is fundamental to the particular fund. The deal or timing may be wrong for that investor without being wrong in any broader sense.

That distinction sounds obvious once said aloud. Yet it is where founders lose months.

The myth: every pass contains product feedback

Why do venture capital firms reject startups without useful feedback? The standard answer is volume. Investors see many pitches. They are busy. They dislike awkward conversations. All true, probably.

But it misses the economics sitting behind the reply.

A venture-capital fund is not a wise person with a chequebook. It is a pool of money with a particular age, strategy and set of prior bets. It may need a certain ownership stake, meaning the share of a company it expects to buy. It may have set aside reserves, money held back to support companies it already owns. It may have a near competitor in its portfolio, the group of companies it has already backed. Or it may simply be past the point at which it is actively making new investments.

None of those facts says much about whether a founder has built a good company.

And several are awkward to explain plainly. “We like this, but another company we backed makes this politically impossible” is not a useful email for anyone. Nor is: “Your round is too small for our model.” Nor: “No partner will champion this internally.”

So the investor writes, “not a fit.” The founder hears, “not good enough.”

Those are radically different messages.

What the polite email is protecting

SheetVenture, a platform that advises founders, examined common reasons investors pass and pointed repeatedly to stage and sector mismatch, inactive deployment, meaning a fund is no longer putting money into new companies, and portfolio conflicts. These are targeting problems before they are company problems.

SheetVenture’s analysis shifts attention from pitch quality to investor fit and deployment timing. Photo: Jan van der Wolf / Pexels, Pexels licence (free commercial use).

Imagine two investors hear the identical pitch on the same afternoon. One has money allocated for companies at that stage and no competing investment. The other has deployed most of its fund, has limited follow-on capacity, meaning limited ability to invest again later, and already owns something close to the company being pitched.

The first investor may ask for data, bring a partner into the next call and set out a process. The second may praise the founders, ask a few broad questions and disappear.

Same business. Different answer.

Here is the twist: the second investor may be doing the founder a favour by not manufacturing a long list of cosmetic objections. If the real answer is a structural no, there is no product tweak that turns it into a yes.

CRV’s distinction matters because it redirects the founder’s scarce time. A company-actionable no says: improve the evidence. An investor-fit no says: find a different investor. Confusing the two turns fundraising into a particularly expensive form of self-doubt.

This is also why a good first call can end in ghosting. A good call establishes that the company is interesting. It does not establish that the firm can invest. Those are separate gates, and founders often see only the first one.

The evidence nobody puts in the rejection email

A pass can also be deliberately vague because a detailed written explanation has a cost.

The National Bureau of Economic Research has documented historical US cases including *Keith v. Black Diamond* in 1999 and *Goldman v. Pogo.com* in 2002, involving investor conduct around dilution and shifts in control that harmed founders. The cases are not proof that every investor avoids feedback because it fears court. They do show why investment firms have reason to be careful about records, characterisations and promises around sensitive decisions.

Historical disputes help explain why investment firms may keep sensitive decisions vague. Photo: Astrophobe / Wikimedia Commons, CC BY-SA 4.0.

Suppose an investor writes that a founder is unsuitable, that a company resembles another portfolio business, or that it will invest after a particular milestone. Those words can later be read as evidence of bias, a promise, a conflict or a misleading representation. A generic response is not always gracious. It can be risk management.

This is where most people stop looking. They assume the choice is between honest feedback and investor indifference. Often there is a third explanation: the investor is protecting its future options.

That option value, the benefit of keeping a future choice open, is real. An investor may want to see whether the company reaches more traction, whether a market changes, or whether a portfolio conflict disappears. A firm can want the door left ajar without wanting to commit, explain itself in detail or create a written trail.

That does not make ghosting good practice. It does explain why a founder may receive flattering words with no usable diagnosis.

Feedback is not handed out equally

There is a harder complication. Sometimes the weakness is not in the business or the fund. It is in the evaluation.

A March 2025 study in the *Journal of Business Venturing* found that atypical founders, including women and Black women, received less supportive and lower-quality feedback even when the idea inputs were identical. In other words, feedback quality itself was not a neutral measurement device.

That finding should change how founders interpret a thin response. “No detailed feedback” is not reliable proof that there was no case to make. It may reflect stereotype-driven risk aversion, not a hard fact about the venture.

Put the three cases side by side and a pattern appears that none of the reports quite states outright. CRV shows that some passes are fund-specific. SheetVenture shows that targeting determines many outcomes before diligence begins. The academic research shows that even the quality of an explanation can be unevenly distributed.

The uncomfortable implication is this: investor feedback is not an objective product-testing service. It is an output of a private institution’s incentives, constraints and judgement, sometimes distorted judgement.

Founders should listen closely. They should not surrender their own diagnosis to it.

When a no really is about the company

The mythbuster has a limit. Not every vague pass is structural, and pretending otherwise is just another comforting story.

YC, the startup programme and investor, has aggregated rejection data suggesting that roughly 80% of its rejections cluster around identifiable, actionable issues such as progress, market and team-market fit. TechCrunch, the technology publication, also published detailed reasons for declining investments in 2016. Transparency is possible where a firm has the culture, process and incentive to provide it.

A repeated, specific signal deserves attention. If several well-matched investors independently ask the same question about customer demand, progress or whether the team understands its market, that is evidence. It may hurt. It is still valuable.

The difference is repetition and specificity. “Come back with more evidence that customers will pay” is a testable claim. “Not a fit right now” is usually not.

This is why founders should avoid the ritual of rebuilding a product after every rejection. A better approach is to fund the proof, not the fantasy: identify the one or two facts an appropriately matched investor would need to believe, then raise enough to establish them.

Read the process, not the praise

When investors ghost after a pitch, founders tend to reread the call for verbal clues. That is understandable and often unhelpful. The behaviour around the call carries more information.

Did the investor request documents? Did they ask questions that became more precise rather than more general? Did they introduce another partner? Did they explain a decision process and then follow it? Did they test the company’s customer evidence or merely compliment the vision?

None of these signs guarantees an investment. But together they distinguish curiosity from institutional motion.

A short, early pass after basic questions often points to fit: stage, sector, cheque size or portfolio. A late pass after substantial requests may reveal a company concern, a financing-structure concern, or a partner decision that failed to form. A partner champion is the person inside the firm willing to argue for the deal. Without one, enthusiasm from a junior team member is not an investment process. It is a conversation.

At first glance, this can feel cynical. It is actually liberating. You do not need to decode every adjective in an investor’s email. You need to ask what the process demonstrated.

GI Network’s view: Treat a pass as information about two systems, not one: your company and the investor’s ability to buy it. Only change the company when the evidence points there.

What operators should do on Monday

First, classify the no before acting. Use four buckets: company-actionable, financing-structure-actionable, investor-fit-actionable and non-actionable.

Company-actionable means the investor gave a concrete, recurring concern about progress, market or team fit. Seek corroboration from other well-matched investors before changing course.

Financing-structure-actionable means the business may be interesting, but the raise is mis-sized, mis-timed or framed in a way the investor cannot support. The answer may be a smaller round, clearer milestones or a different type of capital. Founders should also understand what ownership they are trading away, as explored in how much company to give up for growth capital.

Investor-fit-actionable means the fund is wrong: too early, too late, inactive, conflicted or simply outside its strategy. Remove it from the active list. Do not audition for a role that does not exist.

Non-actionable means there is too little evidence to know. Do not invent certainty. Keep building, preserve relationships and collect more data from the next conversations.

Second, ask questions that make a structural answer easier to give. “Is this primarily about company readiness, or your fund’s current fit?” is better than “Can you give me feedback?” So is: “Would a meaningful change in the next six months alter your view?” A clear no points towards investor fit. A milestone points towards company readiness.

Third, keep a rejection ledger. Record the investor’s stage, sector, likely deployment status, existing portfolio, questions asked, diligence requested, partner involvement and final language. After ten or fifteen conversations, patterns become visible. One fuzzy pass means almost nothing. A pattern of identical concerns from suitable firms means something.

What experienced investors are really screening

An investor is not only asking, “Could this company succeed?” They are also asking, “Could this success matter enough to this fund, in this ownership position, at this moment?”

That second question is why apparently strong companies can be passed over. A fund may require a larger stake than the round permits. It may need capital for existing companies. It may be unable to back adjacent businesses. Or its partners may not agree on the bet.

Experienced investors know these filters are part of disciplined decision-making. First-time founders can mistake them for a personal judgement because the result looks identical: no cheque.

The practical answer is not to become suspicious of every investor. It is to qualify the capital source with the same seriousness that investors qualify the company. Before pitching, ask whether the firm invests at this stage, has a relevant strategy, appears active, can write the needed cheque and faces an obvious conflict.

That discipline matters especially when raising feels urgent. As GI Network has argued in Don’t Raise on Empty. Don’t Wait for Perfect Metrics Either, fundraising decisions become distorted when a company lets runway panic choose the audience.

The Four-Door Pass Test

Here is the tool to keep after the next disappointing email. Before changing your company, put the pass through four doors.

Door one: Evidence. Did the investor name a specific, testable company issue? Has another well-matched investor raised the same issue?

Door two: Economics. Could this fund plausibly invest at the cheque size and ownership level required, while keeping money for the companies it already owns?

Door three: Fit. Does the firm’s stage, sector, geography and portfolio make the deal realistic, or was it always a long shot?

Door four: Process. Did behaviour move beyond polite interest: documents, deeper questions, partner involvement and explicit next steps?

If Door One is open and the others are sound, improve the company. If Doors Two or Three are shut, improve the target list. If Door Four never opened, do not rewrite the business plan on the basis of flattery.

The point is not to make rejection painless. It is to stop treating every no as the same kind of no.

A vague VC pass is often not feedback withheld. It is an investor’s internal constraint, translated into the least committal sentence it can safely send.